{"id":7781,"date":"2021-06-07T00:00:00","date_gmt":"2021-06-06T21:00:00","guid":{"rendered":"https:\/\/gennima.com\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/"},"modified":"2021-11-30T18:11:42","modified_gmt":"2021-11-30T16:11:42","slug":"andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis","status":"publish","type":"post","link":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/","title":{"rendered":"Male infertility"},"content":{"rendered":"\n
\"\"<\/figure><\/div>\n\n\n\n

Fertility is not just a female issue.<\/h3>\n\n\n\n

Male fertility is also very important and must be considered. Male infertility is responsible for half of the infertility cases. Today, we have the technology to diagnose it and treat it.<\/p>\n\n\n\n

Intracytoplasmic Sperm Injection (ICSI) along with newer techniques such as Physiological Intracytoplasmic Sperm Injection (PICSI) have helped millions of couples have their babies.<\/p>\n\n\n\n

Let’s look at the tests for male fertility.<\/p>\n\n\n\n

Sperm analysis includes 4 measurement parameters according to the criteria of the World Health Organization:<\/p>\n\n\n\n

\u2022\u00a0Sample volume: must be at least 2ml.<\/p>\n\n\n\n

\u2022 The number of sperm per ml: must be at least 15 million \/ ml<\/p>\n\n\n\n

\u2022 Sperm motility: must be at least 32% (anterior and in situ movement)<\/p>\n\n\n\n

\u2022 The percentage of sperm with normal morphology: must be over 4%.<\/p>\n\n\n\n

The measurement of oxidative stress is highly recommended, too:<\/p>\n\n\n\n

\u2022 The value of oxidative stress should be up to 1.38 mV \/ million. sperm \/ ml<\/p>\n\n\n\n

A sperm sample is considered ‘normal’ when it meets all 5 of the above conditions. However, when the level in some parameters is lower than the limits of the World Health Organization, then it is considered that this man is experiencing \u2018male infertility\u2019, for example:<\/p>\n\n\n\n

\u2022 If the number of sperm is less than 15 million \/ ml, then we say that there is \u2018oligospermia\u2019.<\/p>\n\n\n\n

\u2022 If sperm motility is less than 32%, then we are talking about \u2018asthenospermia\u2019.<\/p>\n\n\n\n

\u2022 If the percentage of sperm with normal morphology is less than 4%, then it is ‘teratospermia’.<\/p>\n\n\n\n

\u2022 There is a possibility of combination of these, such as: oligoasthenospermia (low number and mobility), oligoasthenoteratozoospermia (all parameters low) and so on.<\/p>\n\n\n\n

Based on the results, the fertility expert and embryologists may suggest freezing a low-quality sperm sample for use in a future IVF treatment. Azoospermia
If there are no sperm in the sperm sample, then it is called ‘azoospermia’.<\/p>\n","protected":false},"excerpt":{"rendered":"

Fertility is not just a female issue. Male fertility is also very important and must be considered. Male infertility is responsible for half of the infertility cases. Today, we have the technology to diagnose it and treat it. <\/p>\n","protected":false},"author":1,"featured_media":7782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[129,130],"tags":[140,180,179],"yoast_head":"\nMale infertility - Gennima IVF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Male infertility - Gennima IVF\" \/>\n<meta property=\"og:description\" content=\"Fertility is not just a female issue. Male fertility is also very important and must be considered. Male infertility is responsible for half of the infertility cases. Today, we have the technology to diagnose it and treat it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Gennima IVF\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-06T21:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-30T16:11:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gennima.com\/wp-content\/uploads\/2021\/11\/\u03b1\u03b9\u03c4\u03af\u03b5\u03c2-\u03c5\u03c0\u03bf\u03b3\u03bf\u03bd\u03b9\u03bc\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"940\" \/>\n\t<meta property=\"og:image:height\" content=\"788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"d g\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"d g\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/gennima.com\/#organization\",\"name\":\"\u039c\u03bf\u03bd\u03ac\u03b4\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03c2 \u03a5\u03c0\u03bf\u03b2\u03bf\u03b7\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u0391\u03bd\u03b1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u0393\u03ad\u03bd\u03bd\u03b7\u03bc\u03b1\",\"url\":\"https:\/\/gennima.com\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gennima.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gennima.com\/wp-content\/uploads\/2021\/10\/Featured_homepage-1.jpg\",\"contentUrl\":\"https:\/\/gennima.com\/wp-content\/uploads\/2021\/10\/Featured_homepage-1.jpg\",\"width\":1200,\"height\":628,\"caption\":\"\u039c\u03bf\u03bd\u03ac\u03b4\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03c2 \u03a5\u03c0\u03bf\u03b2\u03bf\u03b7\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u0391\u03bd\u03b1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u0393\u03ad\u03bd\u03bd\u03b7\u03bc\u03b1\"},\"image\":{\"@id\":\"https:\/\/gennima.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gennima.com\/#website\",\"url\":\"https:\/\/gennima.com\/\",\"name\":\"Gennima IVF\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/gennima.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gennima.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\",\"url\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\",\"name\":\"Male infertility - Gennima IVF\",\"isPartOf\":{\"@id\":\"https:\/\/gennima.com\/#website\"},\"datePublished\":\"2021-06-06T21:00:00+00:00\",\"dateModified\":\"2021-11-30T16:11:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gennima.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Male infertility\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\"},\"author\":{\"name\":\"d g\",\"@id\":\"https:\/\/gennima.com\/#\/schema\/person\/4f37c8f7453aa1c4a1945d643d6f6f7c\"},\"headline\":\"Male infertility\",\"datePublished\":\"2021-06-06T21:00:00+00:00\",\"dateModified\":\"2021-11-30T16:11:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/\"},\"wordCount\":294,\"publisher\":{\"@id\":\"https:\/\/gennima.com\/#organization\"},\"keywords\":[\"fertility\",\"male infertility\",\"\u03b1\u03bd\u03b4\u03c1\u03b9\u03ba\u03ae \u03c5\u03c0\u03bf\u03b3\u03bf\u03bd\u03b9\u03bc\u03cc\u03c4\u03b7\u03c4\u03b1\"],\"articleSection\":[\"Blog\",\"\u03a4\u03b1 \u039d\u03ad\u03b1 \u03bc\u03b1\u03c2\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/gennima.com\/#\/schema\/person\/4f37c8f7453aa1c4a1945d643d6f6f7c\",\"name\":\"d g\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gennima.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a5a3ef5aba846aa6cfbc4c246475e65f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a5a3ef5aba846aa6cfbc4c246475e65f?s=96&d=mm&r=g\",\"caption\":\"d g\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Male infertility - Gennima IVF","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/","og_locale":"en_US","og_type":"article","og_title":"Male infertility - Gennima IVF","og_description":"Fertility is not just a female issue. Male fertility is also very important and must be considered. Male infertility is responsible for half of the infertility cases. Today, we have the technology to diagnose it and treat it.","og_url":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/","og_site_name":"Gennima IVF","article_published_time":"2021-06-06T21:00:00+00:00","article_modified_time":"2021-11-30T16:11:42+00:00","og_image":[{"width":940,"height":788,"url":"https:\/\/gennima.com\/wp-content\/uploads\/2021\/11\/\u03b1\u03b9\u03c4\u03af\u03b5\u03c2-\u03c5\u03c0\u03bf\u03b3\u03bf\u03bd\u03b9\u03bc\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2-1.png","type":"image\/png"}],"author":"d g","twitter_card":"summary_large_image","twitter_misc":{"Written by":"d g","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/gennima.com\/#organization","name":"\u039c\u03bf\u03bd\u03ac\u03b4\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03c2 \u03a5\u03c0\u03bf\u03b2\u03bf\u03b7\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u0391\u03bd\u03b1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u0393\u03ad\u03bd\u03bd\u03b7\u03bc\u03b1","url":"https:\/\/gennima.com\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gennima.com\/#\/schema\/logo\/image\/","url":"https:\/\/gennima.com\/wp-content\/uploads\/2021\/10\/Featured_homepage-1.jpg","contentUrl":"https:\/\/gennima.com\/wp-content\/uploads\/2021\/10\/Featured_homepage-1.jpg","width":1200,"height":628,"caption":"\u039c\u03bf\u03bd\u03ac\u03b4\u03b1 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ce\u03c2 \u03a5\u03c0\u03bf\u03b2\u03bf\u03b7\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u0391\u03bd\u03b1\u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae\u03c2 \u0393\u03ad\u03bd\u03bd\u03b7\u03bc\u03b1"},"image":{"@id":"https:\/\/gennima.com\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/gennima.com\/#website","url":"https:\/\/gennima.com\/","name":"Gennima IVF","description":"","publisher":{"@id":"https:\/\/gennima.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gennima.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/","url":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/","name":"Male infertility - Gennima IVF","isPartOf":{"@id":"https:\/\/gennima.com\/#website"},"datePublished":"2021-06-06T21:00:00+00:00","dateModified":"2021-11-30T16:11:42+00:00","breadcrumb":{"@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gennima.com\/en\/"},{"@type":"ListItem","position":2,"name":"Male infertility"}]},{"@type":"Article","@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/#article","isPartOf":{"@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/"},"author":{"name":"d g","@id":"https:\/\/gennima.com\/#\/schema\/person\/4f37c8f7453aa1c4a1945d643d6f6f7c"},"headline":"Male infertility","datePublished":"2021-06-06T21:00:00+00:00","dateModified":"2021-11-30T16:11:42+00:00","mainEntityOfPage":{"@id":"https:\/\/gennima.com\/en\/andriki-ypogonimotita-1-apli-analysi-41-parametroi-diagnosis\/"},"wordCount":294,"publisher":{"@id":"https:\/\/gennima.com\/#organization"},"keywords":["fertility","male infertility","\u03b1\u03bd\u03b4\u03c1\u03b9\u03ba\u03ae \u03c5\u03c0\u03bf\u03b3\u03bf\u03bd\u03b9\u03bc\u03cc\u03c4\u03b7\u03c4\u03b1"],"articleSection":["Blog","\u03a4\u03b1 \u039d\u03ad\u03b1 \u03bc\u03b1\u03c2"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/gennima.com\/#\/schema\/person\/4f37c8f7453aa1c4a1945d643d6f6f7c","name":"d g","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gennima.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a5a3ef5aba846aa6cfbc4c246475e65f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5a3ef5aba846aa6cfbc4c246475e65f?s=96&d=mm&r=g","caption":"d g"}}]}},"_links":{"self":[{"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/posts\/7781"}],"collection":[{"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/comments?post=7781"}],"version-history":[{"count":3,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/posts\/7781\/revisions"}],"predecessor-version":[{"id":8149,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/posts\/7781\/revisions\/8149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/media\/7782"}],"wp:attachment":[{"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/media?parent=7781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/categories?post=7781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gennima.com\/en\/wp-json\/wp\/v2\/tags?post=7781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}